Company Filing History:
Years Active: 2000
Title: Innovations of Nicholas Grammatikakis
Introduction
Nicholas Grammatikakis is an accomplished inventor based in Brighton, MA (US). He has made significant contributions to the field of molecular biology, particularly through his work on nucleic acids.
Latest Patents
Grammatikakis holds a patent for "Nucleic acid encoding vertebrate cdc37." This patent discloses substantially pure nucleic acid sequences that encode vertebrate cdc37. The protein encoded by this nucleic acid is characterized by its ability to bind specifically to various mammalian proteins, including cdk4, cyclin D, cdk2, Rb, hsp90, hsp60, hsp70, Raf-1, MEK-1, SAPK, MAPK, ERK1, P13-K, and the src family of tyrosine kinases. Additionally, the protein is noted for its ability to bind glycosaminoglycan. The patent also outlines diagnostic and therapeutic applications based on the isolation of these nucleic acid sequences. Grammatikakis has 1 patent to his name.
Career Highlights
Nicholas Grammatikakis is affiliated with Tufts University, where he continues to engage in innovative research. His work has contributed to advancements in understanding protein interactions and their implications in various biological processes.
Collaborations
Grammatikakis collaborates with Aliki Grammatikakis, enhancing the scope and impact of their research endeavors.
Conclusion
Nicholas Grammatikakis exemplifies the spirit of innovation in the field of molecular biology through his patented work on nucleic acids. His contributions have the potential to influence both diagnostic and therapeutic applications in medicine.